A Single Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19)
NCT05299359
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronavirus Disease (COVID-19)
Interventions
BIOLOGICAL:
TAK-019
Sponsor
Takeda